Technow has been a member of the board of the life sciences industry association since 2017. BioVectra, which manufactures ingredients for prescription drugs, was sold last year to U.S. Private Equity firm H.I.G. Capital for about C$330 million.
The BioAlliance also announced two new board members: Cheryl Stewart-Walsh and Mohammed Moin. Both execs will serve two-year terms.
Stewart-Walsh is the Atlantic Canadian director for Innovative Medicines Canada – another industry group, based in Ottawa, and focused on supporting member companies’ R&D efforts.
Moin is the CEO of Charlottetown startup Somru BioScience, which is developing antibody tests for research, and more recently, COVID-19 diagnosis. In 2018, the company raised a funding round totaling $7 million, including both dilutive and non-dilutive funding.